Inovio Pharmaceuticals, Inc. (INO) was a big mover last session, as its shares rose over 20% on the day. This continues the uptrend for the healthcare company since Dec 10, as the stock is now up nearly 54%.
In the last 30-day frame, the company did not witness any estimate revision and the Zacks Consensus Estimate hasn’t been in a trend either. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
Inovio currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some other medical stocks worth considering include Lannett Company, Inc. (LCI), Jazz Pharmaceuticals plc (JAZZ) and Questcor Pharmaceuticals, Inc. (QCOR). All these companies carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
INOVIO PHARMACEUTICALS INC (INO): Free Stock Analysis Report
LANNETT COMP (LCI): Free Stock Analysis Report
JAZZ PHARMACEUTICALS PLC IRELAND (JAZZ): Free Stock Analysis Report
QUESTCOR PHARMACEUTICALS INC (QCOR): Free Stock Analysis Report
Zacks Investment Research
- Health Care Industry
- Finance Trading